Scinai Immunotherapeutics Ltd.

Dual-model biopharma: developing NanoAbs for I&I and offering CDMO services.

SCNI | US

Overview

Corporate Details

ISIN(s):: US09073Q3039 (+1 more)
LEI:
Country:: United States of America
Address:: JERUSALEM BIOPARK, 2ND FLOOR, 0 JERUSALEM
Website:: https://www.scinai.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Scinai Immunotherapeutics is a biopharmaceutical company with a dual business model focused on inflammation and immunology (I&I). The company develops a proprietary pipeline of biological products, including alpaca-derived nanosized antibodies (NanoAbs) for autoimmune and infectious diseases, in collaboration with institutions like the Max Planck Institute. Additionally, its Scinai Bio-services business unit operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to other pharmaceutical and biotech companies. These services span process and analytical development, scale-up, and cGMP manufacturing for nonclinical and clinical studies from its state-of-the-art facility.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scinai Immunotherapeutics Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scinai Immunotherapeutics Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Scinai Immunotherapeutics Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Biotech firm developing cell therapies for regenerative medicine and immunotherapy applications.	United States of America	CELZ
CRESCENT BIOPHARMA, INC. A biotech company developing bispecific antibody therapies to treat solid tumors.	United States of America	CBIO
Crinetics Pharmaceuticals, Inc. Develops novel therapeutics for rare endocrine diseases and related tumors.	United States of America	CRNX
CRISPR Therapeutics AG Develops transformative CRISPR gene-based medicines for diseases like sickle cell.	United States of America	CRSP
Crossject Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.	France	ALCJ
CTC BIO, INC. Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.	South Korea	060590
Cue Biopharma, Inc. Develops injectable biologics to selectively activate T cells for oncology & autoimmune disease.	United States of America	CUE
Cullinan Therapeutics, Inc. Developing differentiated immune-modulating therapies for cancer and autoimmune diseases.	United States of America	CGEM
CUMBERLAND PHARMACEUTICALS INC Acquires and commercializes branded medicines for acute care, gastroenterology, and oncology.	United States of America	CPIX
Cuorips Inc. Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.	Japan	4894